A pilot phase II study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.Lauren Cobb, Amir A. Jazaeri, Michael W. Bevers et al.|Journal of Clinical Oncology|2022Cited by 34
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosisAnne Knisely, Amir A. Jazaeri, Emily Hinchcliff et al.|Med|2024Cited by 10
ENPAC: phase II trial with safety lead of enzalutamide in combination with paclitaxel and carboplatin for advanced or recurrent endometrioid endometrial adenocarcinomaShannon N. Westin, Robert L. Coleman, Bryan Fellman et al.|Gynecologic Oncology|2021Cited by 6
Intraperitoneal administration of dual immune checkpoint inhibitor therapy in recurrent gynecologic malignancies: Updated results of a phase 1b studyAnne Knisely, Amir A. Jazaeri, Rahul A. Sheth et al.|Gynecologic Oncology|2024Cited by 2